Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11760728 Tead inhibitors and uses thereof

Patent 11760728 was granted and assigned to Ikena Oncology on September, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 14 Mar, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 14 Mar, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11925651 TEAD inhibitors and uses thereof
0
Edits on 20 Sep, 2023
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 20 Sep, 2023
Edits made to:
Infobox (+41 properties)
Article (+109 characters)
‌

 US Patent 11760728 Tead inhibitors and uses thereof

Article

Patent abstract

The present invention provides compounds, compositions thereof, and methods of using the same.

Infobox
Is a
Patent
Patent
Patent Applicant
Ikena Oncology
Ikena Oncology
Current Assignee
Ikena Oncology
Ikena Oncology
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11760728
Patent Inventor Names
Alfredo C. Castro
Date of Patent
September 19, 2023
Patent Application Number
17646787
Date Filed
January 3, 2022
Patent Citations
‌
US Patent 7232835 3,6-Disubstituted azabicyclo derivatives as muscarinic receptor antagonists
‌
US Patent 7473787 Bicyclic [3.1.0] derivatives as glycine transporter inhibitors
‌
US Patent 7488748 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
‌
US Patent 7501443 Flavaxate derivatives as muscarinic receptor antagonists
‌
US Patent 7560551 Aurora kinase modulators and method of use
‌
US Patent 7582643 Heterocyclic compounds useful in treating diseases and conditions
‌
US Patent 7750158 Cannabinoid receptor ligands
‌
US Patent 7902373 Nicotinamide derivatives
‌
US Patent 7932246 Histone deacetylase inhibitors
‌
US Patent 7935725 Aryl-substituted bridged or fused diamines as modulators of leukotriene A
‌
US Patent 8022221 Aurora kinase modulators and method of use
‌
US Patent 8067589 Heterocyclic compounds useful in treating diseases and conditions
‌
US Patent 8124639 Bicyclic [3.1.0] heteroaryl amides as type 1 glycine transport inhibitors
‌
US Patent 8344008 Aryl-substituted bridged or fused diamines as modulators of leukotriene A ydrolase
‌
US Patent 8367719 Aryl-substituted bridged or fused diamines as modulators of leukotriene A
‌
US Patent 8686155 Aurora kinase modulators and method of use
‌
US Patent 8772277 Nitrogen-containing heterocyclic compound
‌
US Patent 8895602 6-pyrazolylamido-3-substituted azabicyclo[3.1.0]hexane compounds as calcium channel inhibitors
‌
US Patent 9186354 Pyrrolidine derived β3 adrenergic receptor agonists
‌
US Patent 9216993 Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereof
‌
US Patent 9242961 Aurora kinase modulators and method of use
‌
US Patent 9505782 Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereof
‌
US Patent 9527830 Inhibitors of the renal outer medullary potassium channel
‌
US Patent 9777002 Inhibitors of the renal outer medullary potassium channel
‌
US Patent 9802919 Compounds
‌
US Patent 10023558 Compounds
‌
US Patent 10160769 Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereof
‌
US Patent 10314823 Substituted 1,2-dihydro-3H-pyrrolo[1,2-c]imidazol-3-one antibacterial compounds
‌
US Patent 11274082 Tead inhibitors and uses thereof
‌
US Patent 11458149 TEAD inhibitors and uses thereof
Patent Primary Examiner
‌
Shawquia Jackson
CPC Code
‌
C07D 233/58

Find more entities like US Patent 11760728 Tead inhibitors and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo